What's new

EMEA-002559-PIP09-23

EMEA-002559-PIP09-23

Mar 14, 2025 - 13:55
 0
EMEA-002559-PIP09-23
EMEA-002559-PIP09-23
Read More

Tags:

Previous Article

Fierce Pharma Asia—Takeda's oncology focus; Sun's Checkpoint buy; Ono-Ionis anti...

Next Article

Sibanye-Stillwater confirms loss of life at Driefontein

Related Posts

Human medicines European public assessment report (EPAR): Seladelpar Gilead, Seladelpar lysine dihydrate, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 25, 2025  0

PSUSA/00010390/202407

PSUSA/00010390/202407

Mar 13, 2025  0

Veterinary medicines European public assessment report (EPAR): Elmaro, maropitant, Antiemetics and antinauseants, Status: Opinion

Veterinary medicines European public assessment report ...

Feb 14, 2025  0